a primary phase of treatment with 300 mg isoniazid ( inh ) , 450 mg rifampicin ( rmp ) and 1200 mg ethambutol ( emb ) daily for 3 months was followed by administration of either inh+rmp or inh+emb for 12 or 18 months after conversion .
C0035608
rifampicin
C0358905
inh+rmp